Cargando…
MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors
Intracellular pathogens have evolved to utilize normal cellular processes to complete their replicative cycles. Pathogens that interface with proliferative cell signaling pathways risk infections that can lead to cancers, but the factors that influence malignant outcomes are incompletely understood....
Autores principales: | Luna, Adrian J., Sterk, Rosa T., Griego-Fisher, Anastacia M., Chung, Joon-Yong, Berggren, Kiersten L., Bondu, Virginie, Barraza-Flores, Pamela, Cowan, Andrew T., Gan, Gregory N., Yilmaz, Emrullah, Cho, Hanbyoul, Kim, Jae-Hoon, Hewitt, Stephen M., Bauman, Julie E., Ozbun, Michelle A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857559/ https://www.ncbi.nlm.nih.gov/pubmed/33481911 http://dx.doi.org/10.1371/journal.ppat.1009216 |
Ejemplares similares
-
Infectious titres of human papillomaviruses (HPVs) in patient lesions, methodological considerations in evaluating HPV infectivity and implications for the efficacy of high-level disinfectants
por: Ozbun, Michelle A., et al.
Publicado: (2021) -
Protamine Sulfate Is a Potent Inhibitor of Human Papillomavirus Infection In Vitro and In Vivo
por: Young, Jesse M., et al.
Publicado: (2022) -
Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition
por: Catalano, Antonella, et al.
Publicado: (2021) -
PPP6C negatively regulates oncogenic ERK signaling through dephosphorylation of MEK
por: Cho, Eunice, et al.
Publicado: (2021) -
Immunotherapy in HPV-Related Oropharyngeal Cancers
por: Roof, Logan, et al.
Publicado: (2023)